Publications
261
Citations
4,528
Est. group size
~19
Recurring co-author estimate
Active years
46
Publishing since 1980
Typically publishes in teams of ~7 · 22% small-team papers (≤3 authors) · across 24 venues
- Progress in Pharmacogenomics Implementation in the United States: Barrier Erosion and Remaining Challenges
Clinical Pharmacology & Therapeutics · 2025
- Pharmacogenetic associations of GATA4 and KCNQ1 with ibrutinib cardiovascular toxicity
Pharmacogenetics and Genomics · 2025
- Reducing Fluorouracil Doses in Patients With Partial Dihydropyrimidine Dehydrogenase Deficiency Is a Treatment Safety Strategy, Not a Panacea of Precision Dosing
JCO Precision Oncology · 2025
- Recommendations for pharmacogenetic testing in clinical practice guidelines in the US
American Journal of Health-System Pharmacy · 2024
- Paclitaxel therapeutic drug monitoring - International association of therapeutic drug monitoring and clinical toxicology recommendations
European Journal of Cancer · 2024
- Using maximum plasma concentration (Cmax) to personalize taxane treatment and reduce toxicity
Cancer Chemotherapy and Pharmacology · 2024
- Pharmacogenetic and clinical risk factors for bevacizumab-related gastrointestinal hemorrhage in prostate cancer patients treated on CALGB 90401 (Alliance)
The Pharmacogenomics Journal · 2024
- Potential association of <i>SULT2A1</i> and <i>ABCG2</i> variant alleles with increased risk for palbociclib toxicity
Pharmacogenomics · 2024
- DPYD Genotype-guided Dose Optimization of 5-Fluorouracil in Individuals with Pancreatic Cancer
SMART-MD journal of precision medicine. · 2024
- Incidence, description, predictors, and consequences of persistent taxane-induced peripheral neuropathy
Current Opinion in Supportive and Palliative Care · 2023
- Reply to H.S. Hochster
Journal of Clinical Oncology · 2023
- Supplementary Table 1 from Cumulative Genetic Risk Predicts Platinum/Taxane-Induced Neurotoxicity
2023
- Supplementary Table 2 from Cumulative Genetic Risk Predicts Platinum/Taxane-Induced Neurotoxicity
2023
- Supplementary Table 4 from Cumulative Genetic Risk Predicts Platinum/Taxane-Induced Neurotoxicity
2023
- Supplementary Table 2 from Cumulative Genetic Risk Predicts Platinum/Taxane-Induced Neurotoxicity
2023
- Journal of Clinical Oncology×23
- Pharmacogenomics×15
- Supportive Care in Cancer×10
- UNC Libraries×10
- Cancer Research×10
- Gloria Xue
Medicine · Indiana University
- Erica Cantor
Medicine · Indiana University
- N. Lynn Henry
Medicine · University of Michigan
- Xiaoyan Wang
Medicine · Indiana University
- Reynold C. Ly
Pharmacology, Toxicology and Pharmaceutics · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile